Medicare will cut billions from 340B, expand site-neutral payments in 2027
BioPharma DiveSydney HallemanNovember 5, 2026
Regulators finalized a rule Wednesday that would slash payments for drugs in the controversial 340B program and equalize some payments between care sites. Hospitals railed against the rule.
